Durvalumab: NICE recommends new lung cancer treatment
Clinical update Previous     Next

Durvalumab: NICE recommends new lung cancer treatment

Daniel Allen Health writer

Essential facts

A new lung cancer immunotherapy treatment should be made available to some lung cancer patients in England, according to the National Institute for Health and Care Excellence (NICE).

Cancer Nursing Practice. 18, 4, 11-11. doi: 10.7748/cnp.18.4.11.s11

You need a subscription to read the full article